Clinical trial
A Cohort Establishment Study of Total Management of Ovarian Cancer (Including Fallopian Tube Cancer and Primary Peritoneal Cancer)
NCT06018935 is registered in ClinicalTrials.gov with Sichuan Cancer Hospital and Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Cohort Establishment Study of Total Management of Ovarian Cancer (Including Fallopian Tube Cancer and Primary Peritoneal Cancer)
- Lead sponsor
- Sichuan Cancer Hospital and Research Institute
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- June 17, 2024
- Completion date
- September 1, 2025
- Enrollment
- 500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ovarian cancer, tumor of female reproductive system